Skip to Content

barr 513 (Acetazolamide Extended Release 500 mg)

Pill imprint barr 513 has been identified as Acetazolamide extended release 500 mg.

Acetazolamide is used in the treatment of mountain sickness / altitude sickness; pseudotumor cerebri; hydrocephalus; glaucoma; edema (and more), and belongs to the drug classes carbonic anhydrase inhibitor anticonvulsants, carbonic anhydrase inhibitors. Risk cannot be ruled out during pregnancy. Acetazolamide 500 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.